» Articles » PMID: 27016783

Gene Expression Profiling Reveals Different Molecular Patterns in G-protein Coupled Receptor Signaling Pathways Between Early- and Late-onset Preeclampsia

Overview
Journal Placenta
Publisher Elsevier
Date 2016 Mar 28
PMID 27016783
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Early-onset preeclampsia and late-onset preeclampsia have been regarded as two different phenotypes with heterogeneous manifestations; To gain insights into the pathogenesis of the two traits, we analyzed the gene expression profiles in preeclamptic placentas. A whole genome-wide microarray was used to determine the gene expression profiles in placental tissues from patients with early-onset (n = 7; <34 weeks), and late-onset (n = 8; >36 weeks) preeclampsia and their controls who delivered preterm (n = 5; <34 weeks) or at term (n = 5; >36 weeks). Genes were termed differentially expressed if they showed a fold-change ≥ 2 and q-value < 0.05. Quantitative real-time reverse transcriptase PCR was used to verify the results. Western blotting was performed to verify the expressions of secreted genes at the protein level.

Results: Six hundred twenty-seven genes were differentially expressed in early-compared with late-onset preeclampsia (177 genes were up-regulated and 450 were down-regulated). Gene ontology analysis identified significant alterations in several biological processes; the top two were immune response and cell surface receptor linked signal transduction. Among the cell surface receptor linked signal transduction-related, differentially expressed genes, those involved in the G-protein coupled receptor protein signaling pathway were significantly enriched. G-protein coupled receptor signaling pathway related genes, such as GPR124 and MRGPRF, were both found to be down-regulated in early-onset preeclampsia. The results were consistent with those of western blotting that the abundance of GPR124 was lower in early-onset compared with late-onset preeclampsia. The different gene expression profiles reflect the different levels of transcription regulation between the two conditions and supported the hypothesis that they are separate disease entities. Moreover, the G-protein coupled receptor signaling pathway related genes may contribute to the mechanism underlying early- and late-onset preeclampsia.

Citing Articles

Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study.

Andresen I, Zucknick M, Degnes M, Angst M, Aghaeepour N, Romero R Sci Rep. 2024; 14(1):30813.

PMID: 39730472 PMC: 11681054. DOI: 10.1038/s41598-024-81277-2.


Integrated bioinformatics analysis reveals that CCBP2 and GPR87 are new GPCR-associated biomarkers for preeclampsia.

Li J, Chen M, Zhang B, Zhao Y Reprod Biol Endocrinol. 2024; 22(1):151.

PMID: 39593099 PMC: 11590348. DOI: 10.1186/s12958-024-01324-5.


Detection and assessment of immune and stromal related risk genes to predict preeclampsia: A bioinformatics analysis with dataset.

Qin H Medicine (Baltimore). 2024; 103(26):e38638.

PMID: 38941397 PMC: 11466178. DOI: 10.1097/MD.0000000000038638.


Elevated expression of glycolytic genes as a prominent feature of early-onset preeclampsia: insights from integrative transcriptomic analysis.

He J, Yang H, Liu Z, Chen M, Ye Y, Tao Y Front Mol Biosci. 2023; 10:1248771.

PMID: 37818100 PMC: 10561389. DOI: 10.3389/fmolb.2023.1248771.


Identification of key genes in the pathogenesis of preeclampsia via bioinformatic analysis and experimental verification.

Gao Y, Wu Z, Liu S, Chen Y, Zhao G, Lin H Front Endocrinol (Lausanne). 2023; 14:1190012.

PMID: 37576963 PMC: 10420078. DOI: 10.3389/fendo.2023.1190012.